Eye Allergy Treatment Market Research Report - Forecast till 2027

Eye Allergy Treatment Market Application And Share Analysis By Type (Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, & Contact Allergic Conjunctivitis), Treatment (Medications & Allergy Shots), And End User (Hospitals & Clinics)-Forecast Till 2027

ID: MRFR/Pharma/2523-CR | April 2019 | Region: Global | 159 pages

Eye Allergy Treatment Market Overview


The Eye Allergy Treatment Market is expected to register CAGR of 5.30% till 2023. Some of the protuberant drivers supporting the growth of global eye allergy treatment market are identified as, increasing prevalence of ophthalmological disorders as rising aging population and changing lifestyle are promoting the rising prevalence of ophthalmological disorders. Favorable government funding by in developed and few developing countries in various government and private organizations are contributing to research and prevention programs for ophthalmic disorders.

Synopsis/Market Dynamics

Constant advancements in the field of treatment of eye allergies to treat patients of every age are propelling the growth of the market. For instance, Bausch & Lomb (a subsidiary of Valeant) develops the new topical corticosteroid, mapracorat (undergoing clinical phase II). Mapracorat is an ophthalmic solution for the treatment of ocular pain and inflammation, eye allergies, and dry eyes. Additionally, companies such as Merck and Co. offers montelukast, a leukotriene receptor antagonist, which is effective in alleviating allergic eye diseases. Several manufacturers are also developing innovative ophthalmic solutions and getting them approved by government regulatory bodies. Additionally, increased competition among existing and new market players to develop feasible and efficient treatments for eye allergies are also contributing to the growth of the market.

Global Eye Allergy Treatment Market Revenue, by Treatment, 2017 (USD Mn)


Global Eye Allergy Treatment Market Revenue, by Treatment, 2017


Sources: MRFR Analysis


Eye Allergy Treatment Market Segmentation


Global eye allergy treatment market has been segmented into type, treatment, and end user.


On the basis of type, it is segmented into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. Vernal keratoconjunctivitis includes palpebral, limbal, corneal, and others.


On the basis of treatment, the eye allergy treatment market has been segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. Decongestants are further sub-segmented into with or without antihistamines. Allergy shots (immunotherapy) is sub-segmented into Subcutaneous Immunotherapy Treatment (SCIT) and Sublingual Immunotherapy Treatment (SLIT). The medication segment is projected to value 1860.78 million in 2023. Its larger market share is due to its effectiveness for the treatment of eye allergy. Moreover, with a lot of options available in the eye allergy treatment market, patients find medications much more acceptable in most cases. The wide acceptance of artificial tear as a first-line treatment option for eye allergy is driving the market.


On the basis of end user, it is segmented into eye hospitals & clinics, medical institutes, research centers, and others.


Global Eye Allergy Treatment Market Share, by Region, 2017 (%)


 


Global Eye Allergy Treatment Market Share, by Region, 2017


Sources: MRFR Analysis


Eye Allergy Treatment Market Regional Analysis


The Americas acquired the largest share of 40.4% is projected to grow at the highest CAGR during the forecast period. The growth of the Americas is due to its rising geriatric population and increasing ophthalmological disorders, causing an increased need for diagnosis and therapeutics. According to the National Eye Institute (NEI), about 3 million cases of conjunctivitis were reported in the US in 2015. This huge prevalence of eye allergies is driving the growth of the eye allergy treatment market.


Additionally, according to the US Census Bureau, in 2016, around 49.2 million residents were aged 65 and above in the US. This huge older population of the US contributed to over 15.2% of the total population which is likely to drive the market. Furthermore, the Americas is witnessing rampant advancements in technology. Thus, this increasing patient pool and increasing per capita income of citizens are going to propel the market growth of eye allergy treatments.


Americas region is followed by Europe, which accounted for the second largest eye allergy treatment market share owing to the rising patient population with eye disorders, availability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the presence of good healthcare infrastructure. Additionally, rising government initiatives are driving the growth of the market. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired.


Asia-Pacific is the fastest growing market for the global eye allergy treatment market. The presence of a huge patient population, rapid development in technology, and the presence of huge opportunities for the development of the market drive the growth of the eye allergy treatment market in Asia-Pacific. Additionally, the rising elderly population is also fueling the market of eye allergy treatments in this region. According to the Asian Development Bank, Asia's elderly population is projected to reach nearly 923 million by 2050. This huge geriatric population is driving the growth of the market.


Eye Allergy Treatment Market Key Players


The prominent players in the global eye allergy treatment market are Allergan Plc, Johnson & Johnson Services Inc, Novartis AG, Bausch Health (Valeant Pharmaceuticals International Inc.), Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Nicox, Akorn Inc., Shire, Nutra Essential OTC, and others.


Some of the key strategies followed by the players operating in the global eye allergy treatment market were innovation, product development, acquisition, and expansion.



  • In 2017 the Novartis AG launched olopatadine hydrochloride ophthalmic solution, a generic version of Pataday eye drop. It is used in the treatment of allergic conjunctivitis. The firm has a presence across the world that enhances its market share.

  • Santen Pharmaceutical Co. Ltd, in October 2018 launched Verkazia eye drops emulsion.

  • Allergan Plc, in August 2016, acquired ForSight VISION5 Inc. (US). With this acquisition, the company aims to strengthen its eye care products portfolio and widen its geographic presence.


Eye Allergy Treatment Market Segmentation


Global Eye Allergy Treatment Market, by Type



  • Seasonal and Perennial Allergic Conjunctivitis

  • Vernal Keratoconjunctivitis

  • Atopic Keratoconjunctivitis

  • Contact Allergic Conjunctivitis

  • Giant Papillary Conjunctivitis


Global Eye Allergy Treatment Market, by Treatment



  • Medications

    • Artificial Tears

    • Decongestants

    • Antihistamine/Mast-Cell Stabilizers

    • Oral Antihistamines

    • Corticosteroids



  • Allergy Shots (Immunotherapy)

    • Subcutaneous Immunotherapy Treatment (SCIT)

    • Sublingual Immunotherapy Treatment (SLIT)




Global Eye Allergy Treatment Market, by End User



  • Hospitals and Clinics

  • Specialty Centers


Global Eye Allergy Treatment Market, by Region



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • Russia

    • France

    • Italy

    • UK

    • Rest of Europe



  • Asia-Pacific

    • China

    • India

    • Japan

    • Rest of Asia-Pacific



  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Rest of Latin America



  • Middle East & Africa


Available Additional Customizations



  • Company Profiles of Other Key Players



  1. Pfizer Inc. (US)

  2. Regeneron Pharmaceuticals, Inc. (US)

  3. Hoffmann-La Roche Ltd (Switzerland)

  4. Santen Pharmaceutical Co., Ltd (Japan)

  5. Valeant (Canada)



  • End User Analysis (Example)


Technological Trends-
Rising new market entrants offering new products for the treatment of eye allergy is driving the growth of the market. The introduction of technologically-advanced and innovative products is driving the eye allergy treatment market. For instance, market players such as Novartis launched Olopatadine Hydrochloride, an ophthalmic solution for the treatment of allergic conjunctivitis. Santen launched Verkazia eye drops emulsion, for the treatment of severe vernal keratoconjunctivitis in children. Additionally, Bausch & Lomb (a subsidiary of Valeant) develops the new topical corticosteroid, mapracorat for the treatment of eye allergy symptoms which is in clinical phase II. These technological advancements and innovations in products are contributing to the growth of eye allergy treatment market.

Intended Audience



  • Eye allergy treatment medicines’ manufacturers

  • Eye allergy treatment medicine and treatment providers

  • Hospitals and clinics

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Report Scope:
Report Attribute/Metric Details
  Market Size   2023: 1860.78 Million
  CAGR   2018-2023: 5.30%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan Plc, Johnson & Johnson Services Inc, Novartis AG, Bausch Health (Valeant Pharmaceuticals International Inc.), Santen Pharmaceutical Co. Ltd, Teva Pharmaceutical Industries Ltd, Nicox, Akorn Inc., Shire, Nutra Essential OTC, and others
  Key Market Opportunities   Emerging Markets Of Eye Allergy Treatment
  Key Market Drivers

  • Increasing Prevalence Of Ophthalmological Disorders
  • Favorable Government Funding
  • Product Advancements


  • Frequently Asked Questions (FAQ) :


    Eye allergy treatment market is projected to grow at a 5.2% CAGR between 2020-2027.

    The Americas is expected to dominate the eye allergy treatment market.

    Rising prevalence of ophthalmological disorders and availability of advanced treatments are the key factors driving the eye allergy treatment market.

    Eye allergy treatment market is predicted to touch USD 6845.3 million by 2023.

    Different end users of the eye allergy treatment market include research centers, medical institutes, eye hospitals and clinics, and others.

    1 Report Prologue

    2 Introduction

    2.1 Definition 17

    2.2 Scope of the Study 17

    2.3 List of Assumptions 18

    2.4 Market Structure 18

    3 Research Methodology

    3.1 Research Process 20

    3.2 Primary Research 21

    3.3 Secondary Research 22

    3.4 Market Size Estimation 23

    3.5 Forecast Model 23

    4 Market Dynamics

    4.1 Introduction 25

    4.2 Drivers 26

    4.2.1 Increasing prevalence of ophthalmological disorders 26

    4.2.2 Favorable government funding 26

    4.2.3 Product advancements 26

    4.3 Restraints 27

    4.3.1 Lack of awareness 27

    4.3.2 Side-effects of certain eye allergy treatments 27

    4.4 Opportunity 27

    4.4.1 Emerging markets of eye allergy treatment 27

    4.5 Mega Trends 28

    4.5.1 Technological Trends 28

    4.6 Macroeconomics 28

    5 Market Factor Analysis

    5.1 Porter’s Five Forces Analysis 30

    5.1.1 Bargaining Power of Suppliers 30

    5.1.2 Bargaining Power of Buyers 30

    5.1.3 Threat of New Entrants 31

    5.1.4 Threat of Substitutes 31

    5.1.5 Intensity of Rivalry 31

    5.2 Investment Opportunity Analysis 31

    5.3 Pricing Analysis 31

    5.4 Demand & Supply: Gap Analysis 32

    5.5 Merger and Acquisition Landscape 32

    5.6 Value Chain Analysis 32

    5.6.1 R&D 33

    5.6.2 Manufacturing 33

    5.6.3 Distribution & Sales 33

    5.6.4 Post-Sales Monitoring 33

    6 Eye Allergy Treatment Market, by Type

    6.1 Introduction 35

    6.2 Seasonal and Perennial Allergic Conjunctivitis 36

    6.3 Vernal Keratoconjunctivitis 37

    6.4 Atopic Keratoconjunctivitis 37

    6.5 Contact Allergic Conjunctivitis 38

    6.6 Giant Papillary Conjunctivitis 38

    7 Eye Allergy Treatment Market, by Treatment

    7.1 Introduction 40

    7.2 Medications 41

    7.2.1 Artificial Tears 43

    7.2.2 Decongestants 43

    7.2.3 Antihistamine/Mast-Cell Stabilizers 44

    7.2.4 Oral Antihistamines 44

    7.2.5 Corticosteroids 45

    7.3 ALLERGY SHOTS (Immunotherapy) 46

    7.3.1 Subcutaneous Immunotherapy Treatment (SCIT) 47

    7.3.2 Sublingual Immunotherapy Treatment (SLIT) 48

    8 Eye Allergy Treatment Market, by End User

    8.1 Introduction 50

    8.2 Hospitals and Clinics 51

    8.3 Specialty Centers 51

    9 Global Eye Allergy Treatment Market, by Region

    9.1 Introduction 53

    9.2 Americas 55

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.2.1 North America 58

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.2.1.1 US 62

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.2.1.2 Canada 64

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.2.2 Latin America 67

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3 Europe 70

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1 Western Europe 73

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.1 Germany 77

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.2 France 79

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.3 UK 82

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.4 Italy 84

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.5 Spain 87

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.1.6 Rest of Western Europe 89

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.3.2 Eastern Europe 92

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4 Asia-Pacific 95

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.1 Japan 98

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.2 China 101

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.3 India 103

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.4 Australia 106

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.5 South Korea 108

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.4.6 Rest of Asia-Pacific 111

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5 Middle East and Africa 114

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.1 Middle East 117

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.1.1 Saudi Arabia 121

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.1.2 UAE 123

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.1.3 Egypt 126

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.1.4 Rest of Middle East 128

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    9.5.2 Africa 131

    Eye Allergy Treatment Market, by Type

    Eye Allergy Treatment Market, by Treatment

    Eye Allergy Treatment Market, by End User

    10 Company Landscape

    10.1 Company Share Analysis 135

    11 Company Profile

    11.1 Allergan Plc 138

    11.1.1 Company Overview 138

    11.1.2 Financial Overview 138

    11.1.3 Products/Services Offered 139

    11.1.4 Key Developments 139

    11.1.5 SWOT Analysis 139

    11.1.6 Key Strategies 139

    11.2 Johnson & Johnson Services Inc. 140

    11.2.1 Company Overview 140

    11.2.2 Financial Overview 140

    11.2.3 Products/Services Offered 141

    11.2.4 Key Developments 141

    11.2.5 SWOT Analysis 141

    11.2.6 Key Strategies 141

    11.3 Novartis AG 142

    11.3.1 Company Overview 142

    11.3.2 Financial Overview 142

    11.3.3 Products/Services Offered 143

    11.3.4 Key Developments 143

    11.3.5 SWOT Analysis 143

    11.3.6 Key Strategies 143

    11.4 Bausch Health (Valeant Pharmaceuticals International Inc.) 144

    11.4.1 Company Overview 144

    11.4.2 Financial Overview (Valeant Pharmaceuticals International Inc.) 144

    11.4.3 Products/Services Offered 145

    11.4.4 SWOT Analysis 145

    11.4.5 Key Developments 145

    11.4.6 Key Strategies 145

    11.5 Santen Pharmaceutical Co. Ltd 146

    11.5.1 Company Overview 146

    11.5.2 Financial Overview 146

    11.5.3 Products/Services Offered 147

    11.5.4 SWOT Analysis 147

    11.5.5 Key Developments 147

    11.5.6 Key Strategies 147

    11.6 Teva Pharmaceutical Industries Ltd 148

    11.6.1 Company Overview 148

    11.6.2 Financial Overview 148

    11.6.3 Products/Services Offered 149

    11.6.4 Key Developments 149

    11.6.5 SWOT Analysis 149

    11.6.6 Key Strategies 149

    11.7 Nicox 150

    11.7.1 Company Overview 150

    11.7.2 Financial Overview 150

    11.7.3 Products/Services Offered 150

    11.7.4 SWOT Analysis 150

    11.7.5 Key Developments 150

    11.7.6 Key Strategies 150

    11.8 Akorn Inc. 151

    11.8.1 Company Overview 151

    11.8.2 Financial Overview 151

    11.8.3 Products/Services Offered 152

    11.8.4 SWOT Analysis 152

    11.8.5 Key Developments 152

    11.8.6 Key Strategies 152

    11.9 Shire 153

    11.9.1 Company Overview 153

    11.9.2 Financial Overview 153

    11.9.3 Products/Services Offered 154

    11.9.4 SWOT Analysis 154

    11.9.5 Key Developments 154

    11.9.6 Key Strategies 154

    11.10 Nutra Essential OTC 155

    11.10.1 Company Overview 155

    11.10.2 Financial Overview 155

    11.10.3 Products/Services Offered 155

    11.10.4 SWOT Analysis 155

    11.10.5 Key Developments 155

    11.10.6 Key Strategies 155

    12 Appendix

    12.1 Discussion Blueprint 157

    12.2 References 158

    13 List of Tables

    TABLE 1 LIST OF ASSUMPTIONS 18

    TABLE 2 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 36

    TABLE 3 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SEASONAL AND PERENNIAL ALLERGIC CONJUNCTIVITIS, BY REGION,

    2020–2027 (USD MILLION) 36

    TABLE 4 GLOBAL EYE ALLERGY TREATMENT MARKET FOR VERNAL KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37

    TABLE 5 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ATOPIC KERATOCONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 37

    TABLE 6 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CONTACT ALLERGIC CONJUNCTIVITIS, BY REGION,

    2020–2027 (USD MILLION) 38

    TABLE 7 GLOBAL EYE ALLERGY TREATMENT MARKET FOR GIANT PAPILLARY CONJUNCTIVITIS, BY REGION, 2020–2027 (USD MILLION) 38

    TABLE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020–2027 (USD MILLION) 41

    TABLE 9 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY TYPE, 2020–2027 (USD MILLION) 42

    TABLE 10 GLOBAL EYE ALLERGY TREATMENT MARKET FOR MEDICATIONS, BY REGION, 2020–2027 (USD MILLION) 42

    TABLE 11 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ARTIFICIAL TEARS, BY REGION, 2020–2027 (USD MILLION) 43

    TABLE 12 GLOBAL EYE ALLERGY TREATMENT MARKET FOR DECONGESTANTS, BY REGION, 2020–2027 (USD MILLION) 43

    TABLE 13 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ANTIHISTAMINE/MAST-CELL STABILIZERS, BY REGION,

    2020–2027 (USD MILLION) 44

    TABLE 14 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ORAL ANTIHISTAMINES, BY REGION, 2020–2027 (USD MILLION) 44

    TABLE 15 GLOBAL EYE ALLERGY TREATMENT MARKET FOR CORTICOSTEROIDS, BY REGION, 2020–2027 (USD MILLION) 45

    TABLE 16 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020–2027 (USD MILLION) 46

    TABLE 17 GLOBAL EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY REGION,

    2020–2027 (USD MILLION) 47

    TABLE 18 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBCUTANEOUS IMMUNOTHERAPY TREATMENT (SCIT), BY REGION,

    2020–2027 (USD MILLION) 47

    TABLE 19 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SUBLINGUAL IMMUNOTHERAPY TREATMENT (SLIT), BY REGION,

    2020–2027 (USD MILLION) 48

    TABLE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 50

    TABLE 21 GLOBAL EYE ALLERGY TREATMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020–2027 (USD MILLION) 51

    TABLE 22 GLOBAL EYE ALLERGY TREATMENT MARKET FOR SPECIALTY CENTERSS, BY REGION, 2020–2027 (USD MILLION) 51

    TABLE 23 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 54

    TABLE 24 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 55

    TABLE 25 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 56

    TABLE 26 AMERICAS: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 56

    TABLE 27 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 57

    TABLE 28 AMERICAS: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 57

    TABLE 29 AMERICAS: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 58

    TABLE 30 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

    TABLE 31 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 59

    TABLE 32 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 60

    TABLE 33 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 60

    TABLE 34 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 61

    TABLE 35 NORTH AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 61

    TABLE 36 US: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 62

    TABLE 37 US: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 62

    TABLE 38 US: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 63

    TABLE 39 US: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 63

    TABLE 40 US: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 64

    TABLE 41 CANADA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 64

    TABLE 42 CANADA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 65

    TABLE 43 CANADA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 65

    TABLE 44 CANADA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 66

    TABLE 45 CANADA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 66

    TABLE 46 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 67

    TABLE 47 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 67

    TABLE 48 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 68

    TABLE 49 LATIN AMERICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 68

    TABLE 50 LATIN AMERICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 69

    TABLE 51 EUROPE: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 70

    TABLE 52 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 71

    TABLE 53 EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 71

    TABLE 54 EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 72

    TABLE 55 EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 72

    TABLE 56 EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 73

    TABLE 57 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74

    TABLE 58 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 74

    TABLE 59 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 75

    TABLE 60 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 75

    TABLE 61 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 76

    TABLE 62 WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 76

    TABLE 63 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 77

    TABLE 64 GERMANY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 77

    TABLE 65 GERMANY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 78

    TABLE 66 GERMANY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 78

    TABLE 67 GERMANY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 79

    TABLE 68 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 79

    TABLE 69 FRANCE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 80

    TABLE 70 FRANCE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 80

    TABLE 71 FRANCE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 81

    TABLE 72 FRANCE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 81

    TABLE 73 UK: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 82

    TABLE 74 UK: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 82

    TABLE 75 UK: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 83

    TABLE 76 UK: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 83

    TABLE 77 UK: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 84

    TABLE 78 ITALY: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 84

    TABLE 79 ITALY: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 85

    TABLE 80 ITALY: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 85

    TABLE 81 ITALY: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 86

    TABLE 82 ITALY: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 86

    TABLE 83 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 87

    TABLE 84 SPAIN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 87

    TABLE 85 SPAIN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 88

    TABLE 86 SPAIN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 88

    TABLE 87 SPAIN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 89

    TABLE 88 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 89

    TABLE 89 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 90

    TABLE 90 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 90

    TABLE 91 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 91

    TABLE 92 REST OF WESTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 91

    TABLE 93 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 92

    TABLE 94 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 92

    TABLE 95 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 93

    TABLE 96 EASTERN EUROPE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 93

    TABLE 97 EASTERN EUROPE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 94

    TABLE 98 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95

    TABLE 99 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 96

    TABLE 100 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 96

    TABLE 101 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 97

    TABLE 102 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 97

    TABLE 103 ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 98

    TABLE 104 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 98

    TABLE 105 JAPAN: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 99

    TABLE 106 JAPAN: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 99

    TABLE 107 JAPAN: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 100

    TABLE 108 JAPAN: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 100

    TABLE 109 CHINA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 101

    TABLE 110 CHINA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 101

    TABLE 111 CHINA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 102

    TABLE 112 CHINA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 102

    TABLE 113 CHINA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 103

    TABLE 114 INDIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 103

    TABLE 115 INDIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 104

    TABLE 116 INDIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 104

    TABLE 117 INDIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 105

    TABLE 118 INDIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 105

    TABLE 119 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 106

    TABLE 120 AUSTRALIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 106

    TABLE 121 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 107

    TABLE 122 AUSTRALIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 107

    TABLE 123 AUSTRALIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 108

    TABLE 124 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 108

    TABLE 125 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 109

    TABLE 126 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 109

    TABLE 127 SOUTH KOREA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 110

    TABLE 128 SOUTH KOREA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 110

    TABLE 129 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 111

    TABLE 130 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 111

    TABLE 131 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 112

    TABLE 132 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 112

    TABLE 133 REST OF ASIA-PACIFIC: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 113

    TABLE 134 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 114

    TABLE 135 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 115

    TABLE 136 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 115

    TABLE 137 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 116

    TABLE 138 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 116

    TABLE 139 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 117

    TABLE 140 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118

    TABLE 141 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 118

    TABLE 142 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 119

    TABLE 143 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 119

    TABLE 144 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 120

    TABLE 145 MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 120

    TABLE 146 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 121

    TABLE 147 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 121

    TABLE 148 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 122

    TABLE 149 SAUDI ARABIA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 122

    TABLE 150 SAUDI ARABIA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 123

    TABLE 151 UAE: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 123

    TABLE 152 UAE: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 124

    TABLE 153 UAE: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 124

    TABLE 154 UAE: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 125

    TABLE 155 UAE: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 125

    TABLE 156 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 126

    TABLE 157 EGYPT: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 126

    TABLE 158 EGYPT: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 127

    TABLE 159 EGYPT: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 127

    TABLE 160 EGYPT: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 128

    TABLE 161 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 128

    TABLE 162 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 129

    TABLE 163 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 129

    TABLE 164 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020-2027 (USD MILLION) 130

    TABLE 165 REST OF MIDDLE EAST: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 130

    TABLE 166 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TYPE,2020–2027 (USD MILLION) 131

    TABLE 167 AFRICA: EYE ALLERGY TREATMENT MARKET, BY TREATMENT,2020–2027 (USD MILLION) 131

    TABLE 168 AFRICA: EYE ALLERGY TREATMENT MARKET FOR MEDICATION, BY TYPE, 2020-2027 (USD MILLION) 132

    TABLE 169 AFRICA: EYE ALLERGY TREATMENT MARKET FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE, 2020-2027 (USD MILLION) 132

    TABLE 170 AFRICA: EYE ALLERGY TREATMENT, BY END USER, 2020–2027 (USD MILLION) 133


    14 List of Figures

    FIGURE 1 GLOBAL EYE ALLERGY TREATMENT MARKET: MARKET STRUCTURE 18

    FIGURE 2 RESEARCH PROCESS OF MRFR 20

    FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACHES 23

    FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL EYE ALLERGY TREATMENT MARKET 25

    FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL EYE ALLERGY TREATMENT MARKET 30

    FIGURE 6 VALUE CHAIN - GLOBAL EYE ALLERGY TREATMENT MARKET 32

    FIGURE 7 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 35

    FIGURE 8 GLOBAL EYE ALLERGY TREATMENT MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION) 40

    FIGURE 9 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR MEDICATIONS, BY TYPE, 2020 & 2027 (USD MILLION) 41

    FIGURE 10 GLOBAL EYE ALLERGY TREATMENT MARKET, FOR ALLERGY SHOTS (IMMUNOTHERAPY), BY TYPE,

    2020 & 2027 (USD MILLION) 46

    FIGURE 11 GLOBAL EYE ALLERGY TREATMENT MARKET, BY END USER, 2020 & 2027 (USD MILLION) 50

    FIGURE 12 GLOBAL EYE ALLERGY TREATMENT MARKET, BY REGION, 2020 & 2027 (USD MILLION) 54

    FIGURE 13 AMERICAS: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 55

    FIGURE 14 NORTH AMERICA: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 58

    FIGURE 15 EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 70

    FIGURE 16 WESTERN EUROPE: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 73

    FIGURE 17 ASIA-PACIFIC: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 95

    FIGURE 18 MIDDLE EAST AND AFRICA: EYE ALLERGY TREATMENT MARKET SHARE, BY REGION,2020 (%) 114

    FIGURE 19 MIDDLE EAST: EYE ALLERGY TREATMENT MARKET SHARE, BY COUNTRY,2020 (%) 117

    FIGURE 20 GLOBAL EYE ALLERGY TREATMENT MARKET, COMPANY SHARE ANALYSIS, 2020 135